Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis

Free AI-powered analysis and research for Alnylam Pharmaceuticals, Inc. stock

Sector: Healthcare

Analyze Alnylam Pharmaceuticals, Inc. (ALNY) Stock

Alnylam Pharmaceuticals, Inc. (ALNY) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into ALNY stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for Alnylam Pharmaceuticals, Inc. stock.

📰 Latest Update

Alnylam (ALNY) Is Up 6.3% After Showcasing New Alzheimer’s RNAi Data And $1B-Plus Quarterly Revenue

Wed, July 29, 2026 at 6:10 PM UTC 2 min read

Alnylam Pharmaceuticals (ALNY) shares rose 6.3% following the presentation of promising new RNA interference (RNAi) data related to Alzheimer's disease. This positive development, combined with the company reporting over $1 billion in quarterly revenue, highlights Alnylam's strong financial performance and innovative pipeline. For investors, this news underscores the company's potential for growth and its commitment to advancing treatments in critical therapeutic areas.

Read full article →

Why Analyze Alnylam Pharmaceuticals, Inc. (ALNY) with StockIQ?

• ✅ Free AI-powered analysis of Alnylam Pharmaceuticals, Inc. (ALNY) stock
• ✅ Real-time technical indicators for Alnylam Pharmaceuticals, Inc. stock
• ✅ Comprehensive risk assessment for ALNY
• ✅ No credit card required

People also watch